| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 07/01/2008 | US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 06/26/2008 | WO2008077094A2 Methods for promoting neovascularization |
| 06/26/2008 | WO2008077050A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/26/2008 | WO2008076862A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 06/26/2008 | WO2008076860A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 06/26/2008 | WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 06/26/2008 | WO2008076295A1 Method and compositions for improving pulmonary hypertension |
| 06/26/2008 | WO2008076247A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008076246A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008076245A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008075978A2 An extract |
| 06/26/2008 | WO2008075949A1 Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075117A1 Apovincaminic acid or its ethyl ester derivative for the treatment of microangiopathies |
| 06/26/2008 | WO2008075104A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | WO2008075028A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074975A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | WO2008074679A2 4-imidazolines as taar's ligands |
| 06/26/2008 | WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 06/26/2008 | WO2008074253A1 Pyridazinoindole derivatives, their preparation and therapy use |
| 06/26/2008 | WO2008074098A1 Pharmaceutical composition |
| 06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
| 06/26/2008 | WO2008036247A8 Renin inhibitors |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2007106912A3 Peroxisome-proliferator activated receptor-alpha agonists for organ preservation |
| 06/26/2008 | US20080153926 Methods and compositions for modulating mitochondrial alderhyde dehydrogenase-2 |
| 06/26/2008 | US20080153910 Lysine in therapeutic angiogenesis for cardiac and cerebral/neural reperfusion |
| 06/26/2008 | US20080153902 E.g., 2 N-(2-Fluorophenyl)-5(S)-amino-4(S)-hydroxy-2(S)-isopropyl-7(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; renin inhibitors used for the treatment of hypertension, heart failure, glaucoma, myocardial infarction, kidney failure, restenoses or stroke |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153896 Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof |
| 06/26/2008 | US20080153893 Pyrazole Carboxamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 06/26/2008 | US20080153890 Phosphinic Amino Acid Compounds |
| 06/26/2008 | US20080153889 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)- 6-amino-2-(11-(nonyloxy)undec-8-enamido)hexanoic acid; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153840 Reduction of cardiovascular symptoms |
| 06/26/2008 | US20080153827 treatment or prevention of cardiac hypertrophy or diastolic heart failure resulting from cardiac hypertrophy by administering levosimendan or its metabolite (II) or any of their pharmaceutically acceptable salts to a mammal in need of such treatment |
| 06/26/2008 | US20080153804 Gamma D-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 06/26/2008 | US20080153803 Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 06/26/2008 | US20080153801 Benzoxazepine compounds, their production and use |
| 06/26/2008 | US20080153761 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 06/26/2008 | US20080153739 Compositions and methods for treatment of hyperplasia |
| 06/26/2008 | US20080153738 Compositions and methods for treatment of hyperplasia |
| 06/26/2008 | US20080152718 Bi-layer core isradipine; sustained release |
| 06/26/2008 | US20080152717 Enhanced bioavailability; solvent spray drying |
| 06/26/2008 | US20080152712 N-[1-oxo-3-methyl-4-((3-(3-fluorophenyl)-pyridin-6-yl)ethenyl)naphtho[2,3-c]furan-7-yl]butanamide bisulfate; administerable to unconscious patients suffering from acute coronary syndrome |
| 06/26/2008 | US20080152709 Clonidine composition and method of use |
| 06/26/2008 | US20080152707 Solubilized CoQ-10 and Carnitine |
| 06/26/2008 | US20080152686 Adding microscopic porosity to the surface of a microcoil to be used for medical implantation |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152635 Methods and compositions for correction of cardiac conduction disturbances |
| 06/26/2008 | US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy |
| 06/26/2008 | US20080152588 Metal Chelators and Methods of Their Use |
| 06/26/2008 | CA2673419A1 Pharmaceutical composition |
| 06/26/2008 | CA2673214A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2673119A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 06/26/2008 | CA2672983A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | CA2672976A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672286A1 Organic compounds |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/26/2008 | CA2671838A1 4-imidazolines as taar's ligands |
| 06/26/2008 | CA2671673A1 Angiotensin ii receptor antagonists |
| 06/26/2008 | CA2670839A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1935419A1 Hemodynamics improving agent |
| 06/25/2008 | EP1934602A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 06/25/2008 | EP1934245A1 Y2 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1934229A2 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1934207A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 06/25/2008 | EP1934205A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 06/25/2008 | EP1933842A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 06/25/2008 | EP1933841A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 06/25/2008 | EP1933837A2 Liquid pharmaceutical compositions of nimodipine |
| 06/25/2008 | EP1933822A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 06/25/2008 | EP1933819A2 Formulations of aica riboside |
| 06/25/2008 | EP1748990B1 Process for the preparation of telmisartan |
| 06/25/2008 | EP1678499B1 Chemical compound and assay |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208340A Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 06/25/2008 | CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 06/25/2008 | CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA |
| 06/25/2008 | CN101205236A Pyridinedicarboxylic acid vanadyl complexes as well as agent, tablet, capsule and uses thereof |
| 06/25/2008 | CN101205234A Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
| 06/25/2008 | CN101205205A Alanine derivatives |
| 06/25/2008 | CN101204576A Process for preparing cerebroprotein hydrolysate NaCl injection |
| 06/25/2008 | CN101204559A Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof |
| 06/25/2008 | CN101204543A Medicament composite for varixoflowerlimb |